By Fineline Cube China-based Jiangxi Rimag Group Co., Ltd (HKG: 2522) is set to acquire a 70% stake in compatriot firm Guangzhou Gaomai Health Technology Co., Ltd for RMB 54 million (USD 7.5 million). Upon deal closure, Gaomai Health will become a subsidiary of Rimag.
Acquisition Details
The acquisition of Gaomai Health, which specializes in nuclear medicine imaging technology and operational management services, is expected to significantly enhance Rimag’s development, management, and operational capabilities in nuclear medicine projects. This strategic move aims to promote the application of radiopharmaceuticals in PET/CT business and expand the imaging center market and related services in overseas and regional markets.-Fineline Info & Tech